These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34182161)

  • 1. Expression of MRGPRX2 in skin mast cells of patients with maculopapular cutaneous mastocytosis.
    Deepak V; Komarow HD; Alblaihess AA; Carter MC; Metcalfe DD; Ali H
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3841-3843.e1. PubMed ID: 34182161
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mastocytosis in children].
    Wassmer H; Hartmann K
    Dermatologie (Heidelb); 2023 May; 74(5):323-329. PubMed ID: 37140636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive dysfunction and anaphylaxis in pediatric maculopapular cutaneous mastocytosis.
    Gurnee EA; Phung TL; Guo E; Fong A; Tollefson M; Nguyen H; Brandling-Bennett HA; Moriarty N; Paller AS; Huynh T; Lawley LP
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):409-410. PubMed ID: 31279039
    [No Abstract]   [Full Text] [Related]  

  • 4. MRGPRX2: A novel biomarker in mastocytosis?
    Konantz M; Merkel T; Meyer SC; Hartmann K
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):669-671. PubMed ID: 36759088
    [No Abstract]   [Full Text] [Related]  

  • 5. The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity.
    Pyatilova P; Ashry T; Luo Y; He J; Bonnekoh H; Jiao Q; Moñino-Romero S; Hu M; Scheffel J; Frischbutter S; Hermans MAW; Youngblood BA; Maurer M; Siebenhaar F; Kolkhir P
    Front Immunol; 2022; 13():930945. PubMed ID: 35958589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous mastocytosis: A dermatological perspective.
    Di Raimondo C; Del Duca E; Silvaggio D; Di Prete M; Lombardo P; Mazzeo M; Spallone G; Campione E; Botti E; Bianchi L
    Australas J Dermatol; 2021 Feb; 62(1):e1-e7. PubMed ID: 33040350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blisters, Vaccines, and Mast Cells: A Difficult Case of Diffuse Cutaneous Mastocytosis.
    Gupta M; Akin C; Sanders GM; Chan MP; Ross CW; Castells MC
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1370-1372. PubMed ID: 30961844
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
    Azaña JM; Torrelo A; Matito A
    Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to "MRGPRX2: A novel biomarker in mastocytosis?".
    Komarow HD; Carter MC; Metcalfe DD; Ali H
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):671. PubMed ID: 36759089
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urticaria pigmentosa and other types of mastocytosis; attempted classification of cutaneous mastocytoses].
    DEGOS R
    Actas Dermosifiliogr; 1955 Jun; 46(9):759-85. PubMed ID: 13268269
    [No Abstract]   [Full Text] [Related]  

  • 12. Pediatric maculopapular cutaneous mastocytosis: Retrospective review of signs, symptoms, and associated conditions.
    Gurnee EA; Johansen ML; Phung TL; Guo EL; Fong A; Tollefson M; Nguyen H; Brandling-Bennett H; Moriarty N; Paller AS; Huynh TN; Lawley LP
    Pediatr Dermatol; 2021 Jan; 38(1):159-163. PubMed ID: 33068315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in Allergy: Is a Bone Marrow Biopsy Optional or Essential in the Evaluation of the Patient with a Suspected Mast Cell Disorder?
    Greenberger PA; Metcalfe DD
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1134-1138. PubMed ID: 30630762
    [No Abstract]   [Full Text] [Related]  

  • 14. [An infant with macules and papules].
    van der Waa JD; Vredenborg AD
    Ned Tijdschr Geneeskd; 2020 Aug; 164():. PubMed ID: 32940988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors.
    Matito A; Azaña JM; Torrelo A; Alvarez-Twose I
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):351-363. PubMed ID: 30007456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.
    Castells M; Metcalfe DD; Escribano L
    Am J Clin Dermatol; 2011 Aug; 12(4):259-70. PubMed ID: 21668033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bullous mastocytosis; urticaria pigmentosa, diffuse mastocyte reticulosis, bullous eruptions].
    DEGOS R; DELORT J; HEWITT J; CIVATTE J
    Bull Soc Fr Dermatol Syphiligr; 1954; 61(4):340-1. PubMed ID: 13219554
    [No Abstract]   [Full Text] [Related]  

  • 18. Mastocytosis, Quinolones, MRGPRX2, and Anaphylaxis.
    Weiler CR
    J Allergy Clin Immunol Pract; 2019; 7(6):2091-2092. PubMed ID: 31279470
    [No Abstract]   [Full Text] [Related]  

  • 19. Unsatisfactory agreement using current classification of maculopapular cutaneous mastocytosis.
    Brockow K
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):1917-1918. PubMed ID: 34533253
    [No Abstract]   [Full Text] [Related]  

  • 20. Histopathological characteristics are instrumental to distinguish monomorphic from polymorphic maculopapular cutaneous mastocytosis in children.
    Hermans MAW; Pasmans SGMA; Arends NJT; van den Bosch TPP; van Daele PLA; van Doorn MBA; Huisman EJ; Mooyaart AL; Damman J
    Clin Exp Dermatol; 2022 Sep; 47(9):1694-1702. PubMed ID: 35596520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.